Literature DB >> 18076536

Cognitive impairment in later life in patients with early-onset bipolar disorder.

Shang-Ying Tsai1, Hsin-Chien Lee, Chiao-Chicy Chen, Yi-Lin Huang.   

Abstract

OBJECTIVES: Cognitive impairment may interfere with psychosocial functioning in bipolar disorder (BD). There is limited information regarding the cognitive function of elderly bipolar patients with onset at a young age. The present study aimed to investigate the frequency and the determinants of cognitive impairment in elderly early-onset bipolar patients.
METHODS: Using the Clock-drawing Test (CDT), the Mini Mental State Examination (MMSE), and the Cognitive Abilities Screening Instrument (CASI), we examined euthymic patients with bipolar I disorder in Taiwan, aged 60 years and older. Clinical data were obtained by reviewing medical records and personal interviews with patients and their family members. The onset of BD prior to the age of 40 years is defined as 'early-onset'.
RESULTS: Of the 52 early-onset patients, 42.3% were determined to have cognitive impairment by exhibiting either abnormal CDT or education-adjusted MMSE scores. In a multiple regression model, years of education and the age at the last manic/hypomanic (but not depressive) episode accounted for the greatest variance in both MMSE and CASI scores. While educational level and the age at the last manic/hypomanic episode were not considered in the regression model, onset with depressive syndrome and current age explained 21.5% of the variance in MMSE scores. Age at the first depressive episode, the first manic episode before the age of 40 years, and comorbid diabetes accounted for 16.7% of the variance in CASI scores.
CONCLUSIONS: There appeared to be a sizable proportion of elderly early-onset bipolar patients having cognitive impairment. It is suggested that clinical manifestation of first-onset affective episode and impact of medical comorbidity affect the cognition of early-onset BD in later life.

Entities:  

Mesh:

Year:  2007        PMID: 18076536     DOI: 10.1111/j.1399-5618.2007.00498.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  12 in total

1.  Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.

Authors:  Robert L Findling; Sanjeev Pathak; Willie R Earley; Sherry Liu; Melissa DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 3.  Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.

Authors:  Cynthia V Calkin
Journal:  Ann Med       Date:  2019-08-27       Impact factor: 4.709

4.  The effect of cognitive impairment on mental healthcare costs for individuals with severe psychiatric illness.

Authors:  R Scott Mackin; Kevin L Delucchi; Robert W Bennett; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

Review 5.  Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder.

Authors:  Peijun Chen; Annemiek Dols; Soham Rej; Martha Sajatovic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

6.  Interactive relationships of Type 2 diabetes and bipolar disorder with cognition: evidence of putative premature cognitive ageing in the UK Biobank Cohort.

Authors:  Elysha Ringin; David W Dunstan; Roger S McIntyre; Michael Berk; Neville Owen; Susan L Rossell; Tamsyn E Van Rheenen
Journal:  Neuropsychopharmacology       Date:  2022-10-15       Impact factor: 8.294

Review 7.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

8.  Genome-wide association study of early-onset bipolar I disorder in the Han Taiwanese population.

Authors:  Lawrence Shih-Hsin Wu; Ming-Chyi Huang; Cathy Shen-Jang Fann; Hsien-Yuan Lane; Chian-Jue Kuo; Wei-Che Chiu; Pui-Yan Kwok; Andrew Tai-Ann Cheng
Journal:  Transl Psychiatry       Date:  2021-05-20       Impact factor: 6.222

9.  Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.

Authors:  R Lopes; L Fernandes
Journal:  Depress Res Treat       Date:  2012-05-28

10.  Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.

Authors:  Bernardo Dell'Osso; Massimiliano Buoli; Riccardo Riundi; Nazario D'Urso; Sara Pozzoli; Roberta Bassetti; Emanuela Mundo; A Carlo Altamura
Journal:  Neuropsychiatr Dis Treat       Date:  2009       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.